Xintian Pharmaceutical Co., Ltd.

Implementation Announcement of the 2025 Annual Equity Distribution

Announcement on the Results of Repurchased Shares Sale and the Sale Proportion Reaching 1% and Share Changes

Announcement on the Completion of Industrial and Commercial Change Registration and Reissuance of Business License

Announcement on Extension of Pledge for Partial Shares by Controlling Shareholder

Announcement on the Passive Dilution of Shareholding Ratio of Controlling Shareholders Touching 1%

Pre-disclosure Announcement on the Controlling Shareholder's Plan to Reduce Company Shares

Announcement on the Progress of Selling Repurchased Shares and the First Sale of Repurchased Shares

Announcement on Resolutions from the 12th Meeting of the 5th Board of Directors

Announcement on Participation in the 2026 Investor Reception Day for Listed Companies in Guizhou and the 2025 Annual Performance Presentation Meeting

Legal opinion for the 2025 annual shareholders' meeting

Resolution announcement of the 2025 annual shareholders' meeting

Announcement on Receiving Dividend Payments from Wholly-owned Subsidiary

Announcement on Abnormal Stock Trading Fluctuations and Risk Warning

Announcement on the extension of pledge of part of the shares by the controlling shareholder

Announcement on Obtaining Invention Patent Certificate

Announcement of the Resolutions of the Sixth Meeting of the Eighth Board of Directors

Announcement on the Plan to Sell Part of the Repurchased Shares through Centralized Bidding

Announcement on Appointing Financial and Internal Control Audit Institutions for 2026

Independent Director's 2025 Annual Report (Guan Feng)

Independent Director's 2025 Annual Report (Gao Lijin)

Independent Director's 2025 Annual Report (Zhang Jie)

Announcement on Holding the 2025 Annual Performance Online Briefing Session

2025 Annual Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Directors' and Senior Management's Compensation Management System (March 2026)

Announcement on the Compensation Plan for Directors and Senior Management for 2026

Announcement on Organizational Structure Adjustment

Announcement on Change in Accounting Policies

Articles of Association (March 2026)

Comparison Table of Amendments to the Articles of Association

Announcement on Requesting the Shareholders' Meeting to Authorize the Board of Directors to Handle the Issuance of Shares to Specific Objects through a Simplified Procedure

Review Opinions of the Second Special Meeting of Independent Directors of the Eighth Board of Directors

Announcement on Estimated Daily Related Party Transactions for 2026

Notice of Convening the 2025 Annual General Meeting of Shareholders

Announcement of Resolutions of the Fifth Meeting of the Eighth Board of Directors

Announcement on the 2025 Annual Profit Distribution Plan

Assessment Report on the Performance of the Accounting Firm in 2025

2025 Annual Performance Report of the Board of Directors' Audit Committee

2025 Annual Work Report of the Board of Directors

Special Explanation on the Occupation of Funds by Controlling Shareholders and Other Related Parties in 2025

Summary Table of Non-Operating Fund Occupation and Other Related Party Fund Transactions in 2025

Special Report of the Board of Directors on the Assessment of Independent Directors' Independence

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on Controlling Shareholder Pledging Shares and Releasing Part of the Pledge

Announcement on the Controlling Shareholder Pledging Shares and Releasing Part of the Pledge